Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1+ Subsets in Mouse Immunocompetent Models.

Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide Treatment

Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses

Clonal dynamics in osteosarcoma defined by RGB marking

SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications

Sarcoma treatment in the era of molecular medicine.

Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice